Dalim Losartan Potassium Tablet 100 Milligrams
Losartan Potassium
Prescription medication
Dalim Biotech, Co., Ltd.
MFDS item code 201902685 · Approved 2019.04.26
This product's status changed to Approval withdrawn on 2023.07.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medication is used for the treatment of hypertension and helps prevent and manage kidney disease in patients with hypertension and type 2 diabetes. It effectively controls blood pressure, reduces the burden on the heart and kidneys, and improves vascular health. Therefore, it is beneficial for protecting kidney function in patients with hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same total daily dose may be divided and administered orally twice daily, or the dose may be increased to up to 100 mg once daily, if necessary. 2) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 4) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 5) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect was observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this medicine once daily. The dose may be increased to up to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors).
Children and adolescents aged 6 years or older, weighing at least 20 kg but less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Using this medication during pregnancy may increase the risk of reduced lung development, skeletal malformations in the fetus, and hypotension or renal failure in the newborn. This drug should not be given to certain patients, including those allergic to this medication or its components, pregnant women or women of childbearing potential, patients with severe liver disease, and those with hereditary angioedema. Additionally, patients with diabetes or moderate to severe renal impairment should avoid co-administration of this medication with certain other drugs. Elderly patients, patients with hyperkalemia, those with impaired liver function, and patients with valvular heart disease should use this medication cautiously, ensuring that blood pressure does not drop too low. This medication may cause side effects such as muscle cramps, back pain, dizziness, upper respiratory infection, and nasal congestion; serious adverse reactions such as angioedema or liver function abnormalities and renal failure have also been reported. Particularly, potassium levels may increase, so care should be taken not to take it with potassium supplements or potassium-containing medicines. This medication may affect liver and kidney function, so patients with liver or kidney diseases may need to adjust dosage or discontinue use as directed by their physician. Regular checking of blood pressure, kidney function, and electrolyte levels during use is important and immediate consultation with healthcare providers is necessary if symptoms worsen or abnormal reactions occur. Furthermore, this medication may cause dizziness or fainting due to excessive blood pressure reduction, so caution should be exercised during hazardous activities such as high-altitude work or driving. Women who are pregnant or planning to become pregnant should consult a physician before taking this medication, and nursing mothers are advised to avoid taking this medication. In case of overdose, hypotension and changes in heart rate may occur, so it is important to avoid exceeding the prescribed dose and to visit the hospital immediately if any abnormal symptoms arise. Lastly, this medication should be kept out of reach of children and care should be taken not to transfer it to other containers as this may compromise product quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to keep the medication in a dry place between 15 to 30 degrees Celsius. This helps maintain the medication's effectiveness for a longer time.
White droplet-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium
Prescription medication
Dalim Biotech, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.